Altrova Health Income Statement

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Apr '23 Apr 30, 2023
Revenue	0.13	0.03	-	-	-
Revenue Growth	709.59%	-	-	-	-
Cost of Revenue	0.09	0.05	-	-	-
Gross Profit	0.03	-0.02	-	-	-
Selling, General & Admin	1.47	1	2.3	2.2	3.47
Operating Expenses	2.38	1.37	4.33	2.2	3.47
Operating Income	-2.35	-1.39	-4.33	-2.2	-3.47
Interest Expense	-	-	-	-	-0
Interest & Investment Income	0	-	0	0.01	-
Currency Exchange Gain (Loss)	0	-0	-0	0.01	-
Other Non Operating Income (Expenses)	-0.19	-0.22	-0.35	-7.28	-
EBT Excluding Unusual Items	-2.53	-1.61	-4.69	-9.46	-3.47
Merger & Restructuring Charges	-0.24	-0.24	-	-	-
Impairment of Goodwill	-2.49	-2.49	-	-	-
Gain (Loss) on Sale of Investments	-0.03	-0.03	-0.34	-	-
Gain (Loss) on Sale of Assets	-0.07	-0.07	-	-	-
Other Unusual Items	-0.18	0.15	-	-	-
Pretax Income	-5.53	-4.28	-5.02	-9.46	-3.47
Net Income	-5.53	-4.28	-5.02	-9.46	-3.47
Net Income to Common	-5.53	-4.28	-5.02	-9.46	-3.47
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	190	139	75	31	-
Shares Outstanding (Diluted)	190	139	75	31	-
Shares Change	58.05%	84.69%	141.97%	-	-
EPS (Basic)	-0.03	-0.03	-0.07	-0.30	-
EPS (Diluted)	-0.03	-0.03	-0.07	-0.30	-
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Apr '23 Apr 30, 2023
Free Cash Flow	-0.67	-0.96	-3.06	-1.39	0.38
Free Cash Flow Per Share	-0.00	-0.01	-0.04	-0.04	-
Gross Margin	27.76%	-60.55%	-	-	-
Operating Margin	-1862.70%	-4717.12%	-	-	-
Profit Margin	-4393.09%	-14522.72%	-	-	-
Free Cash Flow Margin	-530.75%	-3255.27%	-	-	-
EBITDA	-2.3	-1.39	-4.33	-	-
D&A For EBITDA	0.04	0	0	-	-
EBIT	-2.35	-1.39	-4.33	-2.2	-3.47